A randomised controlled trial of acceptance and commitment therapy (ACT) for psychosis: study protocol

BMC Psychiatry

John Farhall²  Steven C Hayes⁴  David Copolov¹  David J Castle⁵  Frances Shawyer²  Neil Thomas³ 

[1] Florey Institute of Neuroscience and Mental Health, Parkville, Victoria 3052, Australia;School of Psychological Science, La Trobe University, Melbourne, Victoria 3086, Australia;Monash Alfred Psychiatry Research Centre, Melbourne, Victoria 3004, Australia;Department of Psychology, University of Nevada, Reno, Nevada 89557, USA;St Vincent’s Hospital Mental Health, Fitzroy, Victoria 3065, Australia

关键词: Befriending;    Psychological therapy;    Acceptance and commitment therapy (ACT);    Negative symptoms;    Positive symptoms;    Delusions;    Auditory hallucinations;    Schizophrenia;    Psychosis;    Randomised controlled trial (RCT);   

Others  :  1123468
DOI  :  10.1186/1471-244X-14-198

 received in 2014-06-04, accepted in 2014-07-07,  发布年份 2014

【 摘 要 】

Background

Cognitive behavior therapy for psychosis has been a prominent intervention in the psychological treatment of psychosis. It is, however, a challenging therapy to deliver and, in the context of increasingly rigorous trials, recent reviews have tempered initial enthusiasm about its effectiveness in improving clinical outcomes. Acceptance and commitment therapy shows promise as a briefer, more easily implemented therapy but has not yet been rigorously evaluated in the context of psychosis. The purpose of this trial is to evaluate whether Acceptance and Commitment Therapy could reduce the distress and disability associated with psychotic symptoms in a sample of community-residing patients with chronic medication-resistant symptoms.

Methods/Design

This is a single (rater)-blind multi-centre randomised controlled trial comparing Acceptance and Commitment Therapy with an active comparison condition, Befriending. Eligible participants have current residual hallucinations or delusions with associated distress or disability which have been present continuously over the past six months despite therapeutic doses of antipsychotic medication. Following baseline assessment, participants are randomly allocated to treatment condition with blinded, post-treatment assessments conducted at the end of treatment and at 6 months follow-up. The primary outcome is overall mental state as measured using the Positive and Negative Syndrome Scale. Secondary outcomes include preoccupation, conviction, distress and disruption to life associated with symptoms as measured by the Psychotic Symptom Rating Scales, as well as social functioning and service utilisation. The main analyses will be by intention-to-treat using mixed-model repeated measures with non-parametric methods employed if required. The model of change underpinning ACT will be tested using mediation analyses.

Discussion

This protocol describes the first randomised controlled trial of Acceptance and commitment therapy in chronic medication-resistant psychosis with an active comparison condition. The rigor of the design will provide an important test of its action and efficacy in this population.

Trial registration

Australian New Zealand Clinical Trials Registry: ACTRN12608000210370. Date registered: 18 April 2008

【 授权许可】

   
2014 Thomas et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Dickerson FB, Lehman AF: Evidence-based psychotherapy for schizophrenia. J Nerv Ment Dis 2006, 194(1):3-9.
• [2]Morrison AP, Barratt S: What are the components of CBT for psychosis? A Delphi study. Schizophr Bull 2010, 36(1):136-142.
• [3]Gaudiano BA: Cognitive Behavior Therapies for Psychotic Disorders: Current Empirical Status and Future Directions. Clin Psychol Sci Pr 2005, 12(1):33-50.
• [4]Chadwick P, Birchwood M, Trower P: Cognitive Therapy for Delusions, Voices and Paranoia. Chichester: John Wiley & Sons; 1996.
• [5]Garety P, Fowler D, Kuipers E: Cognitive-Behavioral Therapy for medication-resistant symptoms. Schizophr Bull 2000, 26(1):73-86.
• [6]Gould RA, Mueser KT, Bolton E, Mays V, Goff D: Cognitive therapy for psychosis in schizophrenia: an effect size analysis. Schizophr Res 2001, 48:335-342.
• [7]Pilling S, Bebbington P, Kuipers E, Garety P, Geddes J, Orbach G, Morgan C: Psychological treatments in schizophrenia: I. Meta-analysis of family intervention and cognitive behaviour therapy. Psychol Med 2002, 32:763-782.
• [8]Rector N, Beck AT: Cognitive behavioral therapy for schizophrenia: an empirical review. J Nerv Ment Dis 2001, 189:278-287.
• [9]Jones C, Cormac I, Silveira-da-Mota-Neto JI, Campbell C: Cognitive behaviour therapy for schizophrenia. Cochrane Database Syst Rev 2004, 4:CD000524. http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD000524.pub2/pdf webcite
• [10]National Institute for Clinical Excellence: Schizophrenia. London: NICE; 2002.
• [11]National Institute for Clinical Excellence: Psychosis and Schizophrenia in Adults: Treatment and Management. London: NICE; 2014.
• [12]Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines team for the treatment of schizophrenia and related disorders: Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders. Aust NZ J Psychiat 2005, 39(1–2):1-30.
• [13]Tarrier N, Wykes T: Is there evidence that cognitive behaviour therapy is an effective treatment for schizophrenia? A cautious or cautionary tale? Behav Res Ther 2004, 42:1377-1401.
• [14]Jauhar S, McKenna PJ, Radua J, Fung E, Salvador R, Laws KR: Cognitive-behavioural therapy for the symptoms of schizophrenia: systematic review and meta-analysis with examination of potential bias. Brit J Psychiat 2014, 204(1):20-29.
• [15]Lynch D, Laws KR, McKenna PJ: Cognitive behavioural therapy for major psychiatric disorder: does it really work? A meta-analytical review of well-controlled studies. Psychol Med 2010, 40:9-24.
• [16]Jones C, Hacker D, Cormac I, Meaden A, Irving CB: Cognitive behaviour therapy versus other psychosocial treatments for schizophrenia. Cochrane Database Syst Rev 2012, 4:CD008712. http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD008712.pub2/pdf webcite
• [17]Jones C, Hacker D, Cormac I, Meaden A, Irving CB: Cognitive Behavior Therapy Versus Other Psychosocial Treatments for Schizophrenia. Schizophr Bull 2012, 38(5):908-910.
• [18]Birchwood MJ, Shiers D, Smith J: CBT for psychosis: not a quasi-neuroleptic. Brit J Psychiat 2014. http://bjp.rcpsych.org/content/204/1/20/reply#bjprcpsych_el_55218 webcite
• [19]Byrne RE: RE: Cognitive-behavioural therapy for the symptoms of schizophrenia. Brit J Psychiat 2014. http://bjp.rcpsych.org/content/204/1/20/reply#bjprcpsych_el_55218 webcite
• [20]Chadwick P, Lowe CF: Measurement and modification of delusional beliefs. J Consult Clin Psych 1990, 58(2):225-232.
• [21]Garety P, Fowler D, Kuipers E, Freeman D, Dunn G, Bebbington P, Hadley C, Jones S: London-East Anglia randomized controlled trial of cognitive-behavioural therapy for psychosis. II: Predictors of outcome. Brit J Psychiat 1997, 171:420-426.
• [22]McGowan JF, Lavender T, Garety P: Factors in outcome of cognitive-behavioural therapy for psychosis: Users’ and clinicians’ views. Psychol Psychother Theor Res Pract 2005, 78:513-529.
• [23]Cather C, Penn D, Otto M, Goff D: Cognitive therapy for delusions in schizophrenia: models, benefits, and new approaches. J Cognit Psychother 2004, 18(3):207-221.
• [24]Brehm JW: A Theory of Psychological Reactance. New York: Academic Press; 1966.
• [25]Milton F, Patwa VK, Hafner RJ: Confrontation vs belief modification in persistently deluded patients. Brit J Med Psychol 1978, 51:127-130.
• [26]Turkington D, Kingdon D, Turner T: Effectiveness of a brief cognitive-behavioural therapy intervention in the treatment of schizophrenia. Brit J Psychiat 2002, 180:523-527.
• [27]Wykes T, Hayward P, Thomas N, Green N, Surguladze S, Fannon D, Landau S: What are the effects of group cognitive behaviour therapy for voices? A randomised control trial. Schizophr Res 2005, 77(2–3):201-210.
• [28]Durham RC, Guthrie M, Morton RV, Reid D, Treliving LR, Fowler D, MacDonald RR: Tayside-Fife clinical trial of cognitive-behavioural therapy for medication-resistant psychotic symptoms. Brit J Psychiat 2003, 182:303-311.
• [29]Hayes SC, Strosahl KD, Wilson KG: Acceptance and Commitment Therapy: An Experiential Approach to Behavior Change. New York: The Guilford Press; 1999.
• [30]Hayes SC, Strosahl KD, Wilson KG: Acceptance and Commitment Therapy: An Experiential Approach to Behavior Change. 2nd edition. New York: The Guilford Press; 2013.
• [31]Barnes-Holmes Y, Hayes SC, Barnes-Holmes D, Roche B: Relational frame theory: A post-Skinnerian account of human language and cognition. In Advances in Child Development and Behavior. Edited by Reese HW, Robert K. San Diego, CA: Academic Press; 2001:101-138.
• [32]Hayes SC, Luoma JB, Bond FW, Masuda A, Lillis J: Acceptance and commitment therapy: model, processes and outcomes. Behav Res Ther 2006, 44(1):1-25.
• [33]Hayes SC: Acceptance and Commitment Therapy, Relational Frame Theory, and the third wave of behavior therapy. Behav Ther 2004, 35(4):639-665.
• [34]Bach P, Hayes SC: The use of Acceptance and Commitment Therapy to prevent rehospitalization of psychotic patients: a randomized controlled trial. J Consult Clin Psych 2002, 70(5):1129-1139.
• [35]Turkington D, Dudley R, Warman DM, Beck AT: Cognitive-behavioural therapy for schizophrenia: a review. J Psychiat Prac 2004, 10(1):5-16.
• [36]Gaudiano BA, Herbert JD: Acute treatment of inpatients with psychotic symptoms using Acceptance and Commitment Therapy: pilot results. Behav Res Ther 2006, 44:415-437.
• [37]Bach P, Gaudiano BA, Hayes SC, Herbert JD: Acceptance and commitment therapy for psychosis: intent to treat, hospitalization outcome and mediation by believability. Psychosis 2013, 5(2):166-174.
• [38]Shawyer F, Farhall J, Mackinnon A, Trauer T, Sims E, Ratcliff R, Larner C, Thomas N, Castle D, Mullen P, Copolov D: A randomised controlled trial of acceptance-based cognitive behavioural therapy for command hallucinations in psychotic disorders. Behav Res Ther 2012, 50:110-121.
• [39]Shawyer F, Farhall J: Acceptance-based CBT for command hallucinations: rationale, implementation, outcomes and reflections from the TORCH project. In Acceptance and Mindfulness in the Treatment of Psychosis: Current Trends and Future Directions. Edited by Gaudiano BA. New York: Oxford University Press; in press
• [40]Brett-Jones J, Garety PA, Hemsley D: Measuring delusional experiences: a method and its application. Brit J Clin Psychol 1987, 26:257-265.
• [41]Haddock G, McCarron J, Tarrier N, Faragher EB: Scales to measure dimensions of hallucinations and delusions: the psychotic rating scale (PSYRATS). Psychol Med 1999, 29:879-889.
• [42]Peters E, Day S, McKenna J, Orbach G: Delusional ideation in religious and psychotic populations. Br J Clin Psychol 1999, 38(Pt 1):83-96.
• [43]Peters E, Joseph S, Day S, Garety P: Measuring delusional ideation: the 21-item Peters et al. Delusions Inventory (PDI). Schizophr Bull 2004, 30(4):1005-1022.
• [44]Singer AR, Dobson KS: An experimental investigation of the cognitive vulnerability to depression. Behav Res Ther 2007, 45(3):563-575.
• [45]Thomas N: A model for the development of acceptance and mindfulness based therapies: Preoccupation with psychotic experiences as a treatment target. In Acceptance and Mindfulness in the Treatment of Psychosis: Current Trends and Future Directions. Edited by Gaudiano BA. New York: Oxford University Press; in press
• [46]Farhall J, Greenwood KM, Jackson HJ: Coping with hallucinated voices in schizophrenia: a review of self-initiated strategies and therapeutic interventions. Clin Psychol Rev 2007, 27(4):476-493.
• [47]Shawyer F, Farhall J, Sims EF, Copolov D: Command hallucinations in psychosis: acceptance and disengagement as a focus of treatment. In Theory and Practice in Contemporary Australian Cognitive and Behaviour Therapy: Proceedings of the 28th National AACBT Conference. Edited by Jackson M, Murphy G. Melbourne: Australian Association for Cognitive Behaviour Therapy; 2005:5-14.
• [48]Gaudiano BA, Herbert JD: Believability of Hallucinations as a Potential Mediator of Their Frequency and Associated Distress in Psychotic Inpatients. Behav Cogn Psychoth 2006, 34(04):497-502.
• [49]McGlashan TH, Levy ST, Carpenter WT: Integration and sealing over: clinically distinct recovery styles from schizophrenia. Arch Gen Psychiat 1975, 32:1269-1272.
• [50]White R, Gumley A, McTaggart J, Rattrie L, McConville D, Cleare S, Mitchell G: A feasibility study of Acceptance and Commitment Therapy for emotional dysfunction following psychosis. Behav Res Ther 2011, 49(12):901-907.
• [51]Caspi A, Reichenberg A, Weiser M, Rabinowitz J, Kaplan Z, Knobler H, Davidson-Sagi N, Davidson M: Cognitive performance in schizophrenia patients assessed before and following the first psychotic episode. Schizophr Res 2003, 65(2–3):87-94.
• [52]Fioravanti M, Bianchi V, Cinti M: Cognitive deficits in schizophrenia: an updated metanalysis of the scientific evidence. BMC Psychiatry 2012, 12(1):64.
• [53]Tandon R, Keshavan M, Nasrallah H: Schizophrenia, “Just the Facts”: What we know in 2008 Part 1: Overview. Schizophr Res 2008, 100(1–3):4-19.
• [54]First MB, Spitzer RL, Gibbon M, Williams JBW: Structured Clinical Interview for DSM-IV-TR Axis I Disorders-Patient Edition (SCID-I/P, 1/2007 revision). New York, New York: Biometrics Research Department, New York State Psychiatric Institute; 2007.
• [55]Kay SR: Positive and Negative Syndromes in Schizophrenia. New York: Brunner/Mazel; 1991.
• [56]Wechsler D: Wechsler Test of Adult Reading. New York: Psychological Corporation; 2001.
• [57]Bach PA: ACT with the seriously mentally ill. In A Practical Guide to Acceptance and Commitment Therapy. Edited by Hayes SC, Strosahl KD. New York: Springer; 2005.
• [58]Bendall S, Killackey E, Jackson HJ, Gleeson J: Befriending Manual. Melbourne: ORYGEN Research Centre, University of Melbourne; 2003.
• [59]Sensky T, Turkington D, Kingdon D, Scott JL, Scott J, Siddle R, O’Carroll M, Barnes TRE: A randomized controlled trial of cognitive-behavioural therapy for persistent symptoms in schizophrenia resistant to medication. Arch Gen Psychiat 2000, 57(2):165-172.
• [60]Bendall S, Jackson HJ, Killackey E, Allot K, Johnson T, Harrigan S, Gleeson J, McGorry PD: The credibility and acceptability of Befriending as a control therapy in a randomized controlled trial of Cognitive Behaviour Therapy for acute first episode psychosis. Behav Cog Psychoth 2006, 34:277-291.
• [61]Birchwood M, Smith J, Cochrane R, Wetton S, Copestake S: The Social Functioning Scale. The development and validation of a new scale of social adjustment for use in family intervention programmes with schizophrenic patients. Br J Psychiat 1990, 157:853-859.
• [62]Sheehan DV, Harnett-Sheehan K, Raj BA: The measurement of disability. Int Clin Psychopharm 1996, 11(Suppl 3):89-95.
• [63]Jolley S, Garety PA, Ellett L, Kuipers E, Freeman D, Bebbington PE, Fowler DG, Dunn G: A validation of a new measure of activity in psychosis. Schizophr Res 2006, 85(1–3):288-295.
• [64]Gumley A, O’Grady M, McNay L, Reilly J, Power K, Norrie J: Early intervention for relapse in schizophrenia: results of a 12-month randomized controlled trial of cognitive behavioural therapy. Psychol Med 2003, 33(3):419-431.
• [65]Hayes SC, Strosahl KD, Wilson KG, Bissett RT, Pistorello J, Toarmino D, Polusny M,A, Dykstra TA, Batten SV, Bergan J, Stewart SH, Zvolensky MJ, Eifert GH, Bond FW, Forsyth JP, Karekla M, McCurry SM: Measuring experiential avoidance: a preliminary test of a working model. Psychol Rec 2004, 54(4):553-578.
• [66]Bond FW, Hayes SC, Baer RA, Carpenter KM, Guenole N, Orcutt HK, Waltz T, Zettle RD: Preliminary psychometric properties of the Acceptance and Action Questionnaire-II: a revised measure of psychological inflexibility and experiential avoidance. Behav Ther 2011, 42(4):676-688.
• [67]Shawyer F, Ratcliff R, Mackinnon A, Farhall J, Hayes SC, Copolov D: The Voices Acceptance and Action Scale (VAAS): pilot data. J Clin Psychol 2007, 63(6):593-606.
• [68]Drayton M, Birchwood M, Trower P: Early attachment experience and recovery from psychosis. Br J Clin Psychol 1998, 37(Pt 3):269-284.
• [69]McGlashan TH: Recovery style from mental illness and long-term outcome. J Nerv Ment Dis 1987, 175(11):681-685.
• [70]Wechsler D: Wechsler Adult Intelligence Scale—Third Edition (WAIS–III). San Antonio: The Psychological Corporation; 1997.
• [71]Randolf C: Repeatable Battery for the Assessment of Neuropsychological Status. San Antonio: The Psychological Corporation; 1998.
• [72]Randolf C: Repeatable Battery for the Assessment of Neuropsychological Status (RBANS). Supplement 1. Harcourt Assessment; 2006. http://images.pearsonclinical.com/images/PDF/technical_reports/RBANS.pdf webcite
• [73]Gardner DM, Murphy AL, O’Donnell H, Centorrino F, Baldessarini RJ: International consensus study of antipsychotic dosing. Am J Psychiat 2010, 167(6):686-693.
• [74]Attkisson CC, Zwick R: The Client Satisfaction Questionnaire: psychometric properties and correlations with service utilization and psychotherapy outcome. Eval Program Plann 1982, 5(3):233-237.
• [75]Gueorguieva R, Krystal JH: Move over ANOVA: progress in analyzing repeated-measures data and its reflection in papers published in the Archives of General Psychiatry. Arch Gen Psychiat 2004, 61(3):310-317.
• [76]Sheiner LB, Rubin DB: Intention-to-treat analysis and the goals of clinical trials. Clin Pharmacol Ther 1995, 57(1):6-15.
• [77]Houck PR, Mazumdar S, Koru-Sengul T, Tang G, Mulsant BH, Pollock BG, Reynolds CF 3rd: Estimating treatment effects from longitudinal clinical trial data with missing values: comparative analyses using different methods. Psychiat Res 2004, 129(2):209-215.
• [78]Bruce ML, Ten Have TR, Reynolds CF 3rd, Katz II, Schulberg HC, Mulsant BH, Brown GK, McAvay GJ, Pearson JL, Alexopoulos GS: Reducing suicidal ideation and depressive symptoms in depressed older primary care patients: a randomized controlled trial. JAMA 2004, 291(9):1081-1091.
• [79]Sobel ME: Asymptotic confidence intervals for indirect effects in structural equations models. Sociol Methodol 1982, 13:290-312.
• [80]MacKinnon DP, Lockwood CM, Hoffman JM, West SG, Sheets V: A comparison of methods to test mediation and other intervening variable effects. Psychol Methods 2002, 7(1):83-104.
• [81]Preacher KJ, Hayes AF: SPSS and SAS procedures for estimating indirect effects in simple mediation models. Behav Res Methods Instrum Comput 2004, 36(4):717-731.
• [82]Preacher KJ, Hayes AF: Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behav Res Methods 2008, 40(3):879-891.
• [83]Ost LG: Efficacy of the third wave of behavioral therapies: a systematic review and meta-analysis. Behav Res Ther 2008, 46:296-321.
• [84]Wykes T, Steel C, Everitt B, Tarrier N: Cognitive Behavior Therapy for schizophrenia: effect sizes, clinical models, and methodological rigor. Schizophr Bull 2008, 34(3):523-537.